D. Goade

Rodent-borne diseases and their risks for public health

Practice Guidelines for the Management of Community-Acquired Pneumonia in Adults

Hantavirus pulmonary syndrome

Lethal Mutagenesis of Hepatitis C Virus Induced by Favipiravir

VIRAL HEMORRHAGIC FEVERS AND HANTAVIRUS INFECTIONS IN THE AMERICAS

Treatment of hantavirus pulmonary syndrome

Synthesis of 1-β-d-ribofuranosyl-3-ethynyl-[1,2,4]triazole and its in vitro and in vivo efficacy against Hantavirus

Impacts of biodiversity on the emergence and transmission of infectious diseases

Hantaviruses: A Global Disease Problem

Emerging Infectious Diseases of Wildlife-- Threats to Biodiversity and Human Health

Risk factors for human disease emergence

Antiviral Efficacy of Favipiravir against Two Prominent Etiological Agents of Hantavirus Pulmonary Syndrome

Spectrum of Hantavirus Infection: Hemorrhagic Fever with Renal Syndrome and Hantavirus Pulmonary Syndrome

Hantavirus Pulmonary Syndrome, Renal Insufficiency, and Myositis Associated with Infection by Bayou Hantavirus

Placebo-Controlled, Double-Blind Trial of Intravenous Ribavirin for the Treatment of Hantavirus Cardiopulmonary Syndrome in North America